These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 26847491)

  • 1. Evaluation of Speech Amplification Devices in Parkinson's Disease.
    Andreetta MD; Adams SG; Dykstra AD; Jog M
    Am J Speech Lang Pathol; 2016 Feb; 25(1):29-45. PubMed ID: 26847491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of increased vocal intensity on interarticulator timing in speakers with Parkinson’s disease: a preliminary analysis.
    Richardson K; Sussman JE; Stathopoulos ET
    J Commun Disord; 2014; 52():44-64. PubMed ID: 25459460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of an extended version of the lee silverman voice treatment on voice and speech in Parkinson's disease.
    Spielman J; Ramig LO; Mahler L; Halpern A; Gavin WJ
    Am J Speech Lang Pathol; 2007 May; 16(2):95-107. PubMed ID: 17456888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lee Silverman Voice Treatment for people with Parkinson's: audit of outcomes in a routine clinic.
    Wight S; Miller N
    Int J Lang Commun Disord; 2015; 50(2):215-25. PubMed ID: 25469736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term effects of repetitive transcranial magnetic stimulation on speech and voice in individuals with Parkinson's disease.
    Hartelius L; Svantesson P; Hedlund A; Holmberg B; Revesz D; Thorlin T
    Folia Phoniatr Logop; 2010; 62(3):104-9. PubMed ID: 20424465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing disordered speech and voice in Parkinson's disease: a telerehabilitation application.
    Constantinescu G; Theodoros D; Russell T; Ward E; Wilson S; Wootton R
    Int J Lang Commun Disord; 2010; 45(6):630-44. PubMed ID: 20102257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sentence intelligibility before and after voice treatment in speakers with idiopathic Parkinson's disease.
    Cannito MP; Suiter DM; Beverly D; Chorna L; Wolf T; Pfeiffer RM
    J Voice; 2012 Mar; 26(2):214-9. PubMed ID: 22209057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple repair sequences in everyday conversations involving people with Parkinson's disease.
    Griffiths S; Barnes R; Britten N; Wilkinson R
    Int J Lang Commun Disord; 2015; 50(6):814-29. PubMed ID: 26152654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Acceptance of a Lombard-response Device for Hypophonia in Parkinson's Disease.
    Adams S; Kumar N; Rizek P; Hong A; Zhang J; Senthinathan A; Mancinelli C; Knowles T; Jog M
    Can J Neurol Sci; 2020 Sep; 47(5):634-641. PubMed ID: 32389143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Examining the relationship between speech intensity and self-rated communicative effectiveness in individuals with Parkinson's disease and hypophonia.
    Dykstra AD; Adams SG; Jog M
    J Commun Disord; 2015; 56():103-12. PubMed ID: 26188950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility of group voice therapy for individuals with Parkinson's disease.
    Searl J; Wilson K; Haring K; Dietsch A; Lyons K; Pahwa R
    J Commun Disord; 2011; 44(6):719-32. PubMed ID: 21889774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Just-Meaningful Difference in Speech-to-Noise Ratio.
    McShefferty D; Whitmer WM; Akeroyd MA
    Trends Hear; 2016 Feb; 20():. PubMed ID: 26834121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Speech and communication in Parkinson's disease: a cross-sectional exploratory study in the UK.
    Barnish MS; Horton SMC; Butterfint ZR; Clark AB; Atkinson RA; Deane KHO
    BMJ Open; 2017 May; 7(5):e014642. PubMed ID: 28554918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parkinson's disease: speech and voice disorders and their treatment with the Lee Silverman Voice Treatment.
    Ramig LO; Fox C; Sapir S
    Semin Speech Lang; 2004 May; 25(2):169-80. PubMed ID: 15118943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of the LSVT on vowel articulation and coarticulation in Parkinson's disease.
    Sauvageau VM; Roy JP; Langlois M; Macoir J
    Clin Linguist Phon; 2015 Jun; 29(6):424-40. PubMed ID: 25688915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of loudness cues on respiration in individuals with Parkinson's disease.
    Sadagopan N; Huber JE
    Mov Disord; 2007 Apr; 22(5):651-9. PubMed ID: 17266087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of loud and amplified speech on sentence and word intelligibility in Parkinson disease.
    Neel AT
    J Speech Lang Hear Res; 2009 Aug; 52(4):1021-33. PubMed ID: 18978211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Articulatory-acoustic vowel space: application to clear speech in individuals with Parkinson's disease.
    Whitfield JA; Goberman AM
    J Commun Disord; 2014; 51():19-28. PubMed ID: 25074511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Hypophonia in Parkinson's Disease Through Biofeedback in Daily Life Administered with A Portable Voice Accumulator.
    Gustafsson JK; Södersten M; Ternström S; Schalling E
    J Voice; 2024 May; 38(3):800.e27-800.e38. PubMed ID: 34893384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effectiveness of traditional methods and altered auditory feedback in improving speech rate and intelligibility in speakers with Parkinson's disease.
    Lowit A; Dobinson C; Timmins C; Howell P; Kröger B
    Int J Speech Lang Pathol; 2010 Oct; 12(5):426-36. PubMed ID: 20626310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.